Nanomaterials reshape the pulmonary mechanical microenvironment: novel therapeutic strategies for respiratory diseases. [PDF]
Chen LZ, Zheng PF, Cai Q, Chen RN.
europepmc +1 more source
Features of Heart Failure with Preserved Ejection Fraction in Patients with Chronic Obstructive Pulmonary Disease and Systemic Sclerosis-Associated Interstitial Lung Diseases. [PDF]
Ibrayeva L+9 more
europepmc +1 more source
Lung Function Impairment and Risks of Incident Cardiovascular Diseases and Mortality Among People With Type 2 Diabetes: A Prospective Cohort Study. [PDF]
Chen C+5 more
europepmc +1 more source
Respiratory diseases and mortality in non-traumatic patients exposed to the 2023 Türkiye earthquake disasters: a retrospective observational study. [PDF]
Güngör Ö+4 more
europepmc +1 more source
Related searches:
Lung Transplantation for Obstructive Lung Diseases
Seminars in Respiratory and Critical Care Medicine, 2013Chronic obstructive pulmonary disease (COPD) represents one of the most common indications for lung transplantation, accounting for approximately one third of all procedures performed worldwide to date. Despite this extensive experience, questions remain about the appropriate timing of transplantation in the natural history of COPD, the optimal ...
Robert M. Kotloff, Rupal J. Shah
openaire +3 more sources
OBSTRUCTIVE LUNG DISEASE AND SLEEP
Medical Clinics of North America, 1996There is a significant interaction between obstructive lung disease and sleep--sleep is associated with clinical deterioration in obstructive lung disease, and vice versa. Knowledge of the pathophysiology of deterioration in obstructive lung disease during sleep is essential to the understanding of the management of this problem. Recent information has
Ruzica Jokic, Michael F. Fitzpatrick
openaire +3 more sources
Seretide for obstructive lung disease
Expert Opinion on Pharmacotherapy, 2002Seretide (Advair [North America], GlaxoSmithKline) is an inhaler combination formulation intended for the maintenance therapy of obstructive airways disease. Seretide was developed and made available initially as three multi-dose, dry powder inhaler formulations delivering 50 microg/puff of the long acting beta(2) agonist salmeterol and either 100, 250
openaire +3 more sources
Obstructive lung disease like chronic bronchitis, asthma, pulmonary emphysema and their numerous combinations result from acute or chronic influence of noxious factors on the structures of the respiratory system. While in chronic bronchitis and asthma the conducting airways are affected, in pulmonary emphysema the integrity of the pulmonary parenchyma ...
openaire +2 more sources
Measuring exacerbations in obstructive lung disease
Pharmacoepidemiology and Drug Safety, 2009AbstractPurposeUsing hospitalization always has been seen as a solid measurement for exacerbation in pharmacoepidemiology, but might lead to an underestimation of disease exacerbation because of a trend towards outpatient care. The aim of this study was to quantify the incidence of different exacerbation markers in obstructive lung disease and to ...
Wouter W. van Solinge+6 more
openaire +4 more sources
An estimated 1 in 3,000 to 1 in 4,000 persons in the general population have a diagnosis of interstitial lung disease (ILD), and ILDs account for about 15% of all consultations for general pulmonologists. These diseases encompass a group of heterogeneous lung conditions characterized by diffuse involvement of the lung parenchyma and pulmonary ...
openaire +1 more source